To explore the accuracy and robustness of the three signatures further, we generated a novel transcriptomic dataset using the same principal experimental set-up for activation (Jagged1) and blockade (DAPT) of Notch signalling as described above, but this time from a larger panel of 19 breast cancer cell lines (Fig. 2D). The gene discussed is JAG1; the disease is breast cancer.